<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:37:18" record="18984" source="Espacenet">
	<entities>
		<entity ref="Patent18984" type="Patent">
			<semanticIdentifier>brcris::a39659cc25f0791692fbf9c3241b8d0b</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013030801A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102013030801</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013030801A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20131030801</semanticIdentifier>
			<semanticIdentifier>original::102013030801</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102013030801"/>
			<field name="identifier.lattes" value="0110309062427005"/>
			<field name="identifier.espacenet" value="102013030801"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="diterpenos caurânicos com atividade inibitória para a acentilcolinesterase, processo de obtenção, composições farmacêuticas contendo os diterpenos e uso"/>
			<field name="title.lattes" value="DITERPENOS CAURÂNICOS COM ATIVIDADE INIBITÓRIA PARA A ACETILCOLINESTERASE, PROCESSO DE OBTENÇÃO, COMPOSIÇÕES FARMACÊUTICAS CONTENDO OS DITERPENOS E USO"/>
			<field name="depositDate" value="2013-11-29"/>
			<field name="publicationDate" value="2015-10-27"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="HENRIETE DA SILVA VIEIRA"/>
			<field name="inventor" value="JACQUELINE APARECIDA TAKAHASHI"/>
			<field name="inventor" value="RAQUEL LOURENCO DE CASTRO"/>
			<field name="applicant" value="FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE MINAS GERAIS -FAPEMIG"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE MINAS GERAIS - UFMG"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="C07C13/54AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="C"/>
				<field name="group" value="13"/>
				<field name="subgroup" value="54AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/55AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="55AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P25/16AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="25"/>
				<field name="subgroup" value="16AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P25/28AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="25"/>
				<field name="subgroup" value="28AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="C07D223/14AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="223"/>
				<field name="subgroup" value="14AI"/>
			</field>
			<field name="abstract.espacenet" value="diterpenos caurânicos com atividade inibitória para a acetilcolinesterase, processo de obtenção, composições farmacêuticas contendo os diterpenos e uso. a presente invenção compreende a obtenção de derivados caurânicos, preferencialmente as moléculas ent-16-e-oxima-17-nor-cauran-19-oato de etila (40) e ent-13-lactam-13-a-aza-cauran-19-oato de etila (42), que mostraram alto potencial de inibição da enzima acetilcolinesterase (ache), apresentando-se como uma solução para controlar neuropatias degenerativas, preferencialmente, as doenças de alzheimer e de parkinson. essas substâncias apresentaram efeito similar ao encontrado para o fármaco (3ar,8as)- 1 ,3a,8-trimetil- 1 h,2h,3h,3ah,8h,8ah- pirrolo [2,3-b] indol-5-il n-metilcarbamato (fisostigmina), mais conhecido por eserina, com porcentagem de inibição de 99,88 ± 4,99%. a invenção compreende também, as composições farmacêuticas contendo tais compostos e excipientes farmaceuticamente aceitáveis."/>
			<field name="originatesFrom" value="54541654"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013030801"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102013030801"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013030801"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20131030801"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102013030801"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person13180" type="Person">
			<semanticIdentifier>lattes::0110309062427005</semanticIdentifier>
			<field name="identifier.lattes" value="0110309062427005"/>
			<field name="name" value="Henriete da Silva Vieira"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent18984" toEntityRef="Person13180" type="Inventor"/>
	</relations>
</entity-relation-data>
